Evidence map›Paper›PMID 25016083›Full record

ReviewAdvanced drug delivery reviews2014

Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.

William T Phillips, Ande Bao, Andrew J Brenner, Beth A Goins

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. PEGScientific reports · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Past, Present, and Future of Anticancer Nanomedicine.International journal of nanomedicine · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

William T PhillipsDepartment of Radiology, University of Texas Health Science Center San Antonio, Mail Code 7800, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA. Electronic address: Phillips@uthscsa.edu.
Ande BaoDepartment of Radiology, University of Texas Health Science Center San Antonio, Mail Code 7800, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA; Department of Otolaryngology-Head and Neck Surgery, University of Texas Health Science Center San Antonio, Mail Code 7777, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.
Andrew J BrennerCancer Therapy and Research Center, Mail Code 8232, 7979 Wurzbach Road, San Antonio, TX 78229, USA.
Beth A GoinsDepartment of Radiology, University of Texas Health Science Center San Antonio, Mail Code 7800, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
Image-Guided Interventional Cancer Therapy with Liposomal RadionuclidesR01CA131039 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GOINS, BETH A · 2008 to 2010
$832k
NCI NIH HHS 5 P30 CA054174-16NCI NIH HHS P30 CA054174NCI NIH HHS R01 CA131039
6 · The paper itself

Abstract

One of the major limitations of current cancer therapy is the inability to deliver tumoricidal agents throughout the entire tumor mass using traditional intravenous administration. Nanoparticles carrying beta-emitting therapeutic radionuclides that are delivered using advanced image-guidance have significant potential to improve solid tumor therapy. The use of image-guidance in combination with nanoparticle carriers can improve the delivery of localized radiation to tumors. Nanoparticles labeled with certain beta-emitting radionuclides are intrinsically theranostic agents that can provide information regarding distribution and regional dosimetry within the tumor and the body. Image-guided thermal therapy results in increased uptake of intravenous nanoparticles within tumors, improving therapy. In addition, nanoparticles are ideal carriers for direct intratumoral infusion of beta-emitting radionuclides by convection enhanced delivery, permitting the delivery of localized therapeutic radiation without the requirement of the radionuclide exiting from the nanoparticle. With this approach, very high doses of radiation can be delivered to solid tumors while sparing normal organs. Recent technological developments in image-guidance, convection enhanced delivery and newly developed nanoparticles carrying beta-emitting radionuclides will be reviewed. Examples will be shown describing how this new approach has promise for the treatment of brain, head and neck, and other types of solid tumors.

Indexed as

NanoparticlesRadiopharmaceuticalsRadiotherapy, Image-GuidedAnimalsHumansHyperthermia, InducedNeoplasmsRadionuclide ImagingRadiopharmaceuticalsBeta-emitting radionuclidesConvection enhanced deliveryDrug deliveryImagingLiposomesRadionuclide therapyRhenium-186Solid tumor

Identifiers

PMID25016083
PMCPMC4414016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.